Integrated Solutions Metrics, Inc. offers a comprehensive ‘concept to commercialization’ service model within a single FDA-registered site, providing clients with seamless scale-up and reducing the need for costly site transfers—highlighting a focus on efficiency and integrated manufacturing solutions.

Recent Acquisition The recent $475 million acquisition by Catalent Pharma Solutions signals strong industry confidence and positions Metrics as part of a larger global pharmaceutical manufacturing network, enabling potential cross-selling and expanded partnership opportunities.

Market Leadership Metrics is recognized as a leading end-to-end contract development and manufacturing firm since its acquisition by Mayne Pharma in 2012, with a proven track record and a high client retention rate, indicating stable revenue streams and growth potential.

Facility Expansion Expansion of facilities in Greenville, North Carolina, demonstrates ongoing investment in capacity and capability, providing opportunities to support additional clients in formulation development, analytical testing, and commercial manufacturing.

Client Satisfaction Over 95 percent of clients indicated they would work with Metrics again, underscoring high customer satisfaction and the potential for upselling or expanding services within existing accounts.